Concepedia

Cynthia Bernier

CB

10

Publications

762

Citations

10

H-Index

2005

Active since

Affiliations

McGill University(Current)

Mount Sinai Hospital

Xenon Pharmaceuticals (Canada)

Telesta Therapeutics (Canada)

McGill University Health Centre

Cynthia Bernier is an author at McGill University specializing in tumor biology, medicine, and pharmacology.

Top concepts

Publications per year

2005–2022

10

Publications

10

The Small Molecule GMX1778 Is a Potent Inhibitor of NAD <sup>+</sup> Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors

Mark H. Watson, Anne Roulston, Laurent Bélec et al. · Molecular and Cellular Biology · 2009 · 218 citations · Full text

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition

David Gallo, Jordan T.F. Young, Jimmy Fourtounis et al. · Nature · 2022 · 200 citations · Full text

MxA, a Member of the Dynamin Superfamily, Interacts with the Ankyrin-like Repeat Domain of TRPC

Marc Lussier, Sylvie Cayouette, Pascale K. Lepage et al. · Journal of Biological Chemistry · 2005 · 94 citations · Full text

Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777

Pierre Beauparlant, Dominique Bédard, Cynthia Bernier et al. · Anti-Cancer Drugs · 2009 · 60 citations

, , +18

Guiding ATR and PARP inhibitor combinations with chemogenomic screens

Michal Zimmermann, Cynthia Bernier, Beatrice Kaiser et al. · Cell Reports · 2022 · 55 citations · Full text

, , +19

Rows per page

1–5 of 10